Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Carl Borrebaeck


Dr. Carl Borrebaeck is a Co-Founder and serves as Chief Executive Officer & Chairman at PainDrainer. Prof. Carl Borrebaeck is a serial company builder and serves presently as chairman of Immunovia and SenzaGen. He is a Co-Founder & serves as Chief Executive Officer at PainDrainer. Dr. Borrebaeck is the previous Vice-President of Lund University, and serves presently as Director of CREATE Health Cancer Center at Lund University Bioscience. He also serves as a board member at Alligator Bioscience. His main research interests are cancer proteomics for early detection and immuno-oncology. He received the AKZO Nobel Science Award 2009, for his contributions to cancer proteomics and antibody-based therapy, the Research!Sweden Award 2012 for his medical research of value for patients and health organizations, and the Royal Academy of Engineering Sciences Gold Medal 2012 for outstanding contributions to biomedical science.

Primary Investor Type
Angel (individual)
Primary Office
  • Medicon Village Building 601
  • Scheelev├Ągen 2
  • 223 63 Lund
  • Sweden

Carl Borrebaeck Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
000000000 00000000 29-May-2007 00000 00000 00.000 Drug Discovery Generating Revenue/Not Profitable 0000 0000000000 00.0
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Carl Borrebaeck’s full profile, request a free trial.

Carl Borrebaeck Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000000 00000000 23-Nov-2016 000 000.00 Completed
To view this investor’s complete exits history, request access »

Carl Borrebaeck Team (1)

Name Title Deals Funds Boards Office Contact
Carl Borrebaeck Ph.D Angel Investor 0 0 Lund, Sweden